Recruiting
Phase 3

Active Surveillance & Bleomycin, Etoposide, Carboplatin, Cisplatin

Sponsor:

Children's Oncology Group

Code:

NCT03067181

Conditions

Childhood Extracranial Germ Cell Tumor

Extragonadal Embryonal Carcinoma

Germ Cell Tumor

Malignant Germ Cell Tumor

Malignant Ovarian Teratoma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Best Practice

Biopsy

Biospecimen Collection

Bleomycin Sulfate

Carboplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-02. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-03-19.